These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 26459727

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis.
    Li FY, Cheng NS, Mao H, Jiang LS, Cheng JQ, Li QS, Munireddy S.
    World J Surg; 2009 Oct; 33(10):2155-60. PubMed ID: 19641953
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Practical value of applying cdc2 kinase shRNA to chronic proliferative cholangitis in treatment of hepatolithiasis.
    Li FY, Cheng NS, Cheng JQ, Mao H, Jiang LS, Li QS, Zhou Y.
    Hepatogastroenterology; 2009 Oct; 56(94-95):1477-82. PubMed ID: 19950813
    [Abstract] [Full Text] [Related]

  • 9. Biliary antibiotics irrigation for E. coli-induced chronic proliferative cholangitis and hepatolithiasis: A pathophysiological study in rabbits.
    Ma WJ, Wu ZR, Yang Q, Hu HJ, Wang JK, Shi YJ, Li FY, Cheng NS.
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):356-367. PubMed ID: 31420296
    [Abstract] [Full Text] [Related]

  • 10. Suppression of proliferative cholangitis by E2F decoy oligodeoxynucleotide.
    Yoshida M, Yamamoto N, Nitta T, Uehara T, Terao R, Hatano E, Iimuro Y, Yamaoka Y.
    J Surg Res; 2002 Feb; 102(2):95-101. PubMed ID: 11796004
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of chronic proliferative cholangitis with c-myc shRNA.
    Li FY, Cheng NS, Cheng JQ, Mao H, Jiang LS, Li N, He S.
    World J Gastroenterol; 2009 Jan 07; 15(1):95-101. PubMed ID: 19115473
    [Abstract] [Full Text] [Related]

  • 13. Proliferating cell nuclear antigen expression in peribiliary glands of stone-containing intrahepatic bile ducts.
    Lee KT, Sheen PC.
    Dig Dis Sci; 1999 Nov 07; 44(11):2251-6. PubMed ID: 10573370
    [Abstract] [Full Text] [Related]

  • 14. Down stream involvement of the bile duct in hepatolithiasis.
    Lu S, Yan L, Rao L, Xia T, Gou J, Zhang S, Lei S.
    Chin Med J (Engl); 2002 Jan 07; 115(1):62-4. PubMed ID: 11930661
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peroral cholangioscopic treatment of hepatolithiasis: Long-term results.
    Okugawa T, Tsuyuguchi T, K C S, Ando T, Ishihara T, Yamaguchi T, Yugi H, Saisho H.
    Gastrointest Endosc; 2002 Sep 07; 56(3):366-71. PubMed ID: 12196774
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The distribution of secretory immunoglobulin A in the intrahepatic biliary epithelium of patients with hepatolithiasis.
    Hamba H, Kinoshita H, Hirohashi K, Kubo S, Fujio N.
    Surg Today; 1994 Sep 07; 24(9):849-51. PubMed ID: 7865966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.